{"url":"https://lda.senate.gov/api/v1/filings/8fa7f2e9-bbc7-45af-b59d-bfbc31064d4e/","filing_uuid":"8fa7f2e9-bbc7-45af-b59d-bfbc31064d4e","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/8fa7f2e9-bbc7-45af-b59d-bfbc31064d4e/print/","filing_document_content_type":"text/html","income":"75000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Alyssa Specht Garcia","dt_posted":"2026-07-19T14:02:27-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1747 Pennsylvania Ave NW","registrant_address_2":"Suite 875","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":401106285,"url":"https://lda.senate.gov/api/v1/registrants/401106285/","house_registrant_id":null,"name":"CONTINENTAL STRATEGY, LLC","description":"Governmental and Business Consulting","address_1":"1747 Pennsylvania Ave NW","address_2":"Suite 875","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ALYSSA SPECHT GARCIA","contact_telephone":"+1 305-677-2063","dt_updated":"2026-01-27T16:30:48.319200-05:00"},"client":{"id":67071,"url":"https://lda.senate.gov/api/v1/clients/67071/","client_id":67071,"name":"DEXCOM","general_description":"Healthcare company that develops, manufactures, produces, and distributes CGMs.","client_government_entity":null,"client_self_select":false,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-06-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"continuous glucose monitoring","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":148270,"prefix":null,"prefix_display":null,"first_name":"ALEJANDRO","nickname":null,"middle_name":null,"last_name":"GARCIA","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"continuous glucose monitoring","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":148270,"prefix":null,"prefix_display":null,"first_name":"ALEJANDRO","nickname":null,"middle_name":null,"last_name":"GARCIA","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}